These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 16489258
1. The imbalance between metalloproteinases and their tissue inhibitors is involved in the pathogenesis of dermatitis herpetiformis. Zebrowska A, Narbutt J, Sysa-Jedrzejowska A, Kobos J, Waszczykowska E. Mediators Inflamm; 2005 Dec 14; 2005(6):373-9. PubMed ID: 16489258 [Abstract] [Full Text] [Related]
3. Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis. Papakonstantinou E, Dionyssopoulos A, Aletras AJ, Pesintzaki C, Minas A, Karakiulakis G. J Am Acad Dermatol; 2004 Oct 14; 51(4):526-33. PubMed ID: 15389186 [Abstract] [Full Text] [Related]
7. Increased expression of matrix metalloproteinase-2, matrix metalloproteinase-9 and matrix metalloproteinase-13 in lesional skin of bullous pemphigoid. Niimi Y, Pawankar R, Kawana S. Int Arch Allergy Immunol; 2006 Oct 14; 139(2):104-13. PubMed ID: 16374020 [Abstract] [Full Text] [Related]
8. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats. Zhang X, Sakamoto T, Hata Y, Kubota T, Hisatomi T, Murata T, Ishibashi T, Inomata H. Exp Eye Res; 2002 May 14; 74(5):577-84. PubMed ID: 12076079 [Abstract] [Full Text] [Related]
10. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue. Matsunaga Y, Koda M, Murawaki Y. Res Commun Mol Pathol Pharmacol; 2004 May 14; 115-116():143-50. PubMed ID: 17564313 [Abstract] [Full Text] [Related]
14. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis. Milner JM, Rowan AD, Cawston TE, Young DA. Arthritis Res Ther; 2006 May 14; 8(5):R142. PubMed ID: 16919164 [Abstract] [Full Text] [Related]
15. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H. Diabetologia; 2002 Jul 14; 45(7):1011-6. PubMed ID: 12136400 [Abstract] [Full Text] [Related]
16. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Sakata K, Shigemasa K, Nagai N, Ohama K. Int J Oncol; 2000 Oct 14; 17(4):673-81. PubMed ID: 10995877 [Abstract] [Full Text] [Related]
17. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis. Kanyama M, Kuboki T, Kojima S, Fujisawa T, Hattori T, Takigawa M, Yamashita A. J Orofac Pain; 2000 Oct 14; 14(1):20-30. PubMed ID: 11203734 [Abstract] [Full Text] [Related]
19. Purified human chondroitin-4-sulfate reduced MMP/TIMP imbalance induced by iron plus ascorbate in human fibroblast cultures. Campo GM, Avenoso A, Campo S, D'Ascola A, Ferlazzo AM, Samà D, Calatroni A. Cell Biol Int; 2006 Jan 14; 30(1):21-30. PubMed ID: 16275145 [Abstract] [Full Text] [Related]